SAN CARLOS, Calif. (AP) _ Iovance Biotherapeutics Inc. (IOVA) on Tuesday reported a loss of $37 million in its first quarter.
On a per-share basis, the San Carlos, California-based company said it had a loss of 30 cents.
The results missed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 29 cents per share.
Iovance Biotherapeutics shares have climbed 24% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $11.01, a decrease of 28% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IOVA at https://www.zacks.com/ap/IOVA